MIRM Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. (MIRM) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 70% planned / 30% discretionary
Largest single sale: $4.0M.
Where they traded
Last open-market purchase: January 23, 2026 , by Heron Patrick J .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell 10b5-1 | 658 | $100.00 | $65.8K | 616 −51.6% of holding | |
| Peetz Christopher 2 fills | CHIEF EXECUTIVE OFFICER | Sell 10b5-1 | 30,000 | $98.68 | $3.0M | 216,128 −12.2% of holding | |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 40,000 | $100.00 | $4.0M | 1,274 −96.9% of holding | |
| BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 6,001 | $99.90 | $599.5K | 36,355 −14.2% of holding | |
| Peetz Christopher 3 fills | CHIEF EXECUTIVE OFFICER | Sell 10b5-1 | 20,000 | $98.92 | $2.0M | 202,626 −9% of holding | |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell 10b5-1 | 1,840 | $105.29 | $193.7K | 1,274 −59.1% of holding | |
| Peetz Christopher 4 fills | CHIEF EXECUTIVE OFFICER | Sell 10b5-1 | 20,000 | $122.27 | $2.4M | 202,175 −9% of holding | |
| BJERKHOLT ERIC 4 fills | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 5,000 | $122.25 | $611.3K | 44,057 −10.2% of holding | |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell 10b5-1 | 2,721 | $120.00 | $326.5K | 3,114 −46.6% of holding | |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell 10b5-1 | 2,594 | $101.95 | $264.5K | 5,835 −30.8% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.